Profound Medical annual operating margin
2019
2020
2021
2022
2023
2024
2025
Profound Medical's operating margin was −256.27% for fiscal 2025.
View full Profound Medical company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −256.27% | +83.18 pp |
| 2024 | 2024-12-31 | −339.45% | +146.25 pp |
| 2023 | 2023-12-31 | −485.69% | −4.84 pp |
| 2022 | 2022-12-31 | −480.86% | −40.13 pp |
| 2021 | 2021-12-31 | −440.72% | −182.47 pp |
| 2020 | 2020-12-31 | −258.26% | +98.81 pp |
| 2019 | 2019-12-31 | −357.07% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −445.67% | +251.25 pp |
| Q1 2026 | 2026-03-31 | −150.29% | +326.69 pp |
| Q4 2025 | 2025-12-31 | −109.71% | +97.57 pp |
| Q3 2025 | 2025-09-30 | −176.18% | +177.79 pp |
| Q2 2025 | 2025-06-30 | −696.92% | −295.38 pp |
| Q1 2025 | 2025-03-31 | −476.98% | +169.21 pp |
| Q4 2024 | 2024-12-31 | −207.28% | — |
| Q3 2024 | 2024-09-30 | −353.97% | — |
| Q2 2024 | 2024-06-30 | −401.54% | — |
| Q1 2024 | 2024-03-31 | −646.19% | — |
Over the last five reported fiscal years, Profound Medical's operating margin increased from −258.26% to −256.27%, a change of +1.99 percentage points. The latest reported quarter, Q2 2026, shows −445.67%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Profound Medical filings at SEC.gov ↗